View Author
cancer breast breast cancer mutation expression family tumor study brca 1 susceptibility sample breast cancers wild-type allele brca 2 mutations colorectal table e-cadherin analysis chek 2*1100delc control mda-mb transcript variant genet a-catenin chek 2 association level number cell lines protein individual probe identi outlier exons signature colorectal cancer cases patient frequency value 2*1100delc subtype cd 146 breast cancer res genotype cohort outlier breast cancer patients netherland detection identi fied colorectal cancer stage luminal breast cancer risk population probe sets normal-like chek 2 signature gene expression levels epithelial nature glioblastoma fication hnpcc carrier epcam expression level dutch ferro genome-wide association study breast cancer cases gene expression marker status change genetic tumor cells ?/-
9 Most Recent Publications
|
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
(Article)
Nagel, J.H.A. Peeters, J. Klijn, J.G.M. Spek, P.J. van der Foekens, J.A. Martens, J.W.M. Schutte, M. Meijers-Heijboer, H. Smid, M. Sieuwerts, A.M. Wasielewski, M. Weerd, V. de Trapman-Jansen, A.M.A.C. Ouweland, A.M.W. van den Brüggenwirth, H.T. IJcken, W.F.J. van |
2011-05-26
|
|
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
(Article)
Mostert, B. Kraan, J. Sleijfer, S. Bolt-de Vries, J. Spoel, P. van der Sieuwerts, A.M. Schutte, M. Timmermans, A.M. Foekens, R. Martens, J.W.M. Gratama, J-W. |
2011-05-01
|
|
Genome-wide association study identifies five new breast cancer susceptibility loci
(Article)
turnbull, C. Ahmed, S. Hughes, D. Warren-Perry, M. Tapper, W. Eccles, D. Evans, D.G. Hooning, M. Schutte, M. Ouweland, A.M.W. van den Houlston, R. Ross, G. Morrison, J. Langford, C. Pharoah, P.D.P. Stratton, M.R. Dunning, A.M. Rahman, N. Easton, D.F. Pernet, D. Renwick, A. Maranian, M. Seal, S. Ghoussaini, M. Hines, S. Healey, S. |
2010-06-01
|
|
Low-risk susceptibility alleles in 40 human breast cancer cell lines
(Article)
Riaz, M. Elstrodt, F. Hollestelle, A. Dehghan, A. Klijn, J.G.M. Schutte, M. |
2009-07-16
|
|
Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations
(Article)
Hollestelle, A. Elstrodt, F. Timmermans, A.M. Sieuwerts, A.M. Klijn, J.G.M. Foekens, J.A. Bakker, M.A. den Schutte, M. |
2009-01-01
|
|
Exon expression arrays as a tool to identify new cancer genes
(Article)
Schutte, M. Elstrodt, F. Sillevis Smitt, P.A.E. French, P.J. Bralten, L.B.C. Nagel, J.H.A. Duijm, E. Hollestelle, A. Vuerhard, M.J. Wasielewski, M. Peeters, J.K. Spek, P.J. van der |
2008-08-20
|
|
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer
(Article)
Wasielewski, M. Vasen, H. Wijnen, J. Hooning, M. Dooijes, D. Tops, C. Klijn, J.G.M. Meijers-Heijboer, E.J. Schutte, M. |
2008-08-01
|
|
CHEK2 1100delC and male breast cancer in the Netherlands
(Article)
Wasielewski, M. Bakker, M.A. den Ouweland, A.M.W. van den Meijer van Gelder, M.E. Portengen, H. Klijn, J.G.M. Meijers-Heijboer, E.J. Foekens, J.A. Schutte, M. |
2008-01-01
|
|
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
(Article)
Meijers-Heijboer, E.J. Snoo, A. de Schutte, M. McGuffog, L. Thompson, D. Easton, D.F. Sodha, N. Seal, S. Barfoot, R. Mangion, J. Chang-Claude, J. Eccles, D. Oldenburg, R. Eeles, R. Evans, D.G. Houlston, R. Murday, V. Narod, S. Peretz, T. Peto, J. Phelan, C. Zhang, H.X. Szabo, C. Hollestelle, A. Devilee, P. Goldgar, D. Futreal, P.A. Nathanson, K.L. Weber, B.L. Rahman, N. Stratton, M.R. Ouweland, A.M.W. van den Klijn, J.G.M. Wasielewski, M. Houben, M. Elstrodt, F. Crepin, E. Veghel-Plandsoen, M. van Duijn, C.M. van Bartels, C.C.M. Meijers, C. |
2002-05-01
|
